Novo Nordisk halves US price of Ozempic Financial TimesNovo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients CNBCGoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499/month Yahoo FinanceNovo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers ReutersNovo Nordisk to sell weight-loss drug for $499 to eligible customers Fox Business
